BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 18257776)

  • 1. Statins and natural regulatory T cells in HIV infection.
    Mascitelli L; Pezzetta F; Goldstein MR
    HIV Med; 2008 Feb; 9(2):131. PubMed ID: 18257776
    [No Abstract]   [Full Text] [Related]  

  • 2. Complications and side effects. Concerns about statins.
    TreatmentUpdate; 2005; 17(4):5-6. PubMed ID: 17228472
    [No Abstract]   [Full Text] [Related]  

  • 3. Room for manoeuvre when prescribing statins to dyslipidaemic patients on antiretroviral therapy.
    Myers J; Rayment M; Sonecha S; Moyle G; Boffito M
    HIV Med; 2012 Mar; 13(3):190-2. PubMed ID: 22296166
    [No Abstract]   [Full Text] [Related]  

  • 4. Lipid lowering, statins and cancer.
    Wierzbicki AS
    Int J Clin Pract; 2006 Sep; 60(9):1022-4. PubMed ID: 16939539
    [No Abstract]   [Full Text] [Related]  

  • 5. Fenofibric Acid (trilipix).
    Med Lett Drugs Ther; 2009 May; 51(1311):33-4. PubMed ID: 19417718
    [No Abstract]   [Full Text] [Related]  

  • 6. Re: Dyslipidemia is a protective factor in amyotrophic lateral sclerosis.
    Yoshii Y; Ikeda K; Iwamoto K; Kawase Y; Iwasaki Y
    Neurology; 2009 Mar; 72(10):944; author reply 944-5. PubMed ID: 19273834
    [No Abstract]   [Full Text] [Related]  

  • 7. Reducing the residual risk of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor therapy with combination therapy.
    Polonsky TS; Davidson MH
    Am J Cardiol; 2008 Apr; 101(8A):27B-35B. PubMed ID: 18375238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Statins and cancer in patients with asthma.
    Mascitelli L; Pezzetta F; Goldstein MR
    Thorax; 2009 Jun; 64(6):548-9; author reply 549. PubMed ID: 19478124
    [No Abstract]   [Full Text] [Related]  

  • 9. The risk of myopathy associated with thiazolidinediones and statins in patients with type 2 diabetes: a nested case-control analysis.
    Koro CE; Sowell MO; Stender M; Qizilbash N
    Clin Ther; 2008 Mar; 30(3):535-42. PubMed ID: 18405791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipid management in chronic kidney disease, hemodialysis, and transplantation.
    Montague T; Murphy B
    Endocrinol Metab Clin North Am; 2009 Mar; 38(1):223-34. PubMed ID: 19217521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statins and cancer: will we ever know the answer?
    Etminan M; Coogan PF; Rosenberg L
    Epidemiology; 2002 Sep; 13(5):607; author reply 607-8. PubMed ID: 12192235
    [No Abstract]   [Full Text] [Related]  

  • 12. Complications & side effects. Can statins be used as anti-HIV drugs?
    TreatmentUpdate; 2004; 16(7):9. PubMed ID: 17219689
    [No Abstract]   [Full Text] [Related]  

  • 13. Lipid management in the geriatric patient.
    Nair AP; Darrow B
    Endocrinol Metab Clin North Am; 2009 Mar; 38(1):185-206. PubMed ID: 19217519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human Immunodeficiency Virus Infection, Antiretroviral Therapy, and Statin: a Clinical Update.
    Zanetti HR; Roever L; Gonçalves A; Resende ES
    Curr Atheroscler Rep; 2018 Feb; 20(2):9. PubMed ID: 29423787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Statin-fibrate combination therapy.
    Feeman WE
    Am J Cardiol; 2008 May; 101(10):1521. PubMed ID: 18471475
    [No Abstract]   [Full Text] [Related]  

  • 16. The double-edged sword of statin immunomodulation.
    Goldstein MR; Mascitelli L; Pezzetta F
    Int J Cardiol; 2009 Jun; 135(1):128-30. PubMed ID: 18485499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Myopathy with rhabdomyolysis as an adverse effect of simultaneous treatment with cerivastatin and gemfibrozil].
    Huić M; Anić B; Cikes N; Bosnić D; Sentić M; Markeljević J; Mayer M; Pazanin L
    Lijec Vjesn; 2002; 124(3-4):73-6. PubMed ID: 18956824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiretroviral and statin drug-drug interactions.
    Ray GM
    Cardiol Rev; 2009; 17(1):44-7. PubMed ID: 19092370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Combination pharmacotherapy therapy in the management of atherogenic dyslipidemia].
    Kłosiewicz-Latoszek L; Cybulska B
    Kardiol Pol; 2005 Jun; 62 Suppl 2():II76-80. PubMed ID: 19813341
    [No Abstract]   [Full Text] [Related]  

  • 20. Lipid-lowering therapy--benefits and risks.
    Shechter M
    Isr Med Assoc J; 2007 Feb; 9(2):133; author reply 133-4. PubMed ID: 17348492
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.